Journal Article Summary
The article examines the oral health effects of hormonal contraceptive methods in women of reproductive age, highlighting the importance of understanding these potential changes as more women use these contraceptives. Hormonal contraceptives, which include various combinations of estrogen and progesterone, are widely prescribed for family planning and can influence bodily functions, including oral health. Given the increasing prevalence of hormonal contraceptive use, it is crucial to identify any associated oral manifestations to ensure proper dental care and patient education.
In this systematic review, the authors analyzed 13 observational studies published over the past 21 years, focusing on various oral health issues related to hormonal contraceptive use. The findings suggest that women using these contraceptives may have an increased risk of developing conditions such as alveolar osteitis after tooth extractions and a higher presence of Candida species in their mouths. Additionally, the studies indicated that hormonal contraceptives could lead to increased gingival inflammation and worsen periodontal health, particularly in women already susceptible to gum disease.
The review acknowledges several limitations, including the variability in study designs and the potential for bias in some articles. It emphasizes the need for further research to clarify the relationship between hormonal contraceptives and oral health, particularly regarding the type and dosage of hormones used. Patients are encouraged to discuss their use of hormonal contraceptives with their healthcare providers, especially if they notice any changes in their oral health, to ensure appropriate monitoring and care.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Rojo Marta García, Lloret Miguel Ramón Pecci, Gironés Julia Guerrero. Oral manifestations in women using hormonal contraceptive methods: a systematic review. Clinical Oral Investigations 2024. DOI: 10.1007/s00784-024-05573-x. PMID: 38427087. PMCID: PMC10907424.
Featured Pill Pals Product
My Way (Levonorgestrel) 1.5 mg Tablet - Generic For Plan B and Morning After Pill --- Lupin Pharma --- Over The Counter
My Way (Levonorgestrel) 1.5 mg Tablet – Generic For Plan B and Morning After Pill — Lupin Pharma — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
